Drug
Itruvone clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
- PH-10
- 1
Studies by the year they started
4 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Provectus Pharmaceuticals (4)
Studies
Open first, then newest update. How each study uses itruvone is read from its arms, and is right about nine times in ten.
Testing it · 4
- Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for PsoriasisTerminatedPhase 2Provectus PharmaceuticalsNCT00555646Written as PH-10 (rose bengal disodium 0.001%)
- Randomized Study of PH-10 for PsoriasisCompletedPhase 2Provectus PharmaceuticalsNCT01247818Written as PH-10 (0.002% Rose Bengal)
- An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque PsoriasisCompletedPhase 2Provectus PharmaceuticalsNCT00941278Written as PH-10 (0.001% Rose Bengal)
- A Phase 2 Study of PH-10 for the Treatment of Atopic DermatitisCompletedPhase 2Provectus PharmaceuticalsNCT00690807Written as PH-10
Codes
What other systems call itruvone · ClinicalTrials.gg INT015378
- UNII (FDA) 72HML2UK6JITRUVONEConfirmed FDA, Wikidata
- Wikidata Q25204005itruvoneConfirmed FDA, Wikidata
- NCI Thesaurus C188524ItruvoneOne source FDA
- DrugBank DB21543One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 72HML2UK6J | ITRUVONE | Confirmed FDA, Wikidata |
| Wikidata | Q25204005 | itruvone | Confirmed FDA, Wikidata |
| NCI Thesaurus | C188524 | Itruvone | One source FDA |
| DrugBank | DB21543 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.